|
TTC5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.11022302462516E-16 |
| Normal-vs-Stage2 |
1.28789999775947E-08 |
| Normal-vs-Stage3 |
1.11022302462516E-16 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
4.423000E-01 |
| Stage1-vs-Stage3 |
2.302600E-01 |
| Stage1-vs-Stage4 |
4.221400E-04 |
| Stage2-vs-Stage3 |
1.420760E-01 |
| Stage2-vs-Stage4 |
5.164600E-03 |
| Stage3-vs-Stage4 |
5.098200E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
9.34169963606735E-10 |
| Normal-vs-Asian |
2.09250394789251E-11 |
| Caucasian-vs-AfricanAmerican |
8.609200E-01 |
| Caucasian-vs-Asian |
9.688000E-01 |
| AfricanAmerican-vs-Asian |
8.502800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
3.981800E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(41-60Yrs) |
3.33066907387547E-16 |
| Normal-vs-Age(61-80Yrs) |
7.99360577730113E-15 |
| Normal-vs-Age(81-100Yrs) |
8.12470000000065E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.875200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.219400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.700600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.951400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.043600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.883200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.509370E-01 |
| Classical-VS-Follicular |
9.420000E-01 |
| Classical-VS-Other |
5.639000E-01 |
| Classical-VS-Normal |
8.39550651221543E-13 |
| Tall-VS-Follicular |
2.237000E-01 |
| Tall-VS-Other |
8.769600E-01 |
| Tall-VS-Normal |
2.09310346832581E-12 |
| Follicular-VS-Other |
6.890000E-01 |
| Follicular-VS-Normal |
3.88480358992638E-11 |
| Other-VS-Normal |
3.815800E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.11022302462516E-16 |
| Normal-vs-N1 |
1.88737914186277E-15 |
| N0-vs-N1 |
9.961100E-03 |
|
|
